Natus Sensory Acquires TheraB Medical for Wearable Neonatal Phototherapy
Event summary
- Natus Sensory acquired TheraB Medical on February 11, 2026, to expand its neonatal phototherapy offerings.
- TheraB Medical’s SnugLit™ is the first FDA-cleared wearable phototherapy system designed as a swaddle-style garment.
- The acquisition aims to enhance Natus Sensory’s ability to deliver flexible, family-centered care for neonatal jaundice.
- Natus Sensory is an ARCHIMED company, strengthening its global reach in newborn care solutions.
The big picture
The acquisition aligns with the growing trend of wearable medical devices in neonatal care, reflecting a shift toward family-centered treatment models. Natus Sensory’s move underscores the strategic importance of expanding its portfolio to include innovative, flexible solutions that cater to evolving clinical needs. The deal also highlights the increasing consolidation in the medical technology sector, particularly in specialized areas like neonatal care.
What we're watching
- Integration Challenges
- How Natus Sensory will integrate TheraB Medical’s wearable technology into its existing hospital-based solutions.
- Market Expansion
- Whether the acquisition will accelerate Natus Sensory’s global reach in neonatal care.
- Regulatory Compliance
- The pace at which Natus Sensory can scale SnugLit’s FDA-cleared technology across different care settings.
Related topics